| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Revenue | $397K | -55.8% |
| Cost of Revenue | $203K | -74.1% |
| Gross Profit | $194K | +71.7% |
| R&D Expense | $2.3M | +150.8% |
| SG&A Expense | $13.3M | +68.1% |
| Operating Income | -$15.4M | -76.8% |
| Interest Expense | $5K | +66.7% |
| Pre-tax Income | -$15.0M | -70.4% |
| Income Tax | $0 |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $10.5M | -28.1% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $125K | -28.6% |
| Inventory | $3.5M | -35.2% |
| Current Assets | $15.1M | -35.7% |
| Total Assets | $26.8M | -25.2% |
| Current Liabilities | $2.4M | +3.1% |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.5M | +30.9% |
| Capital Expenditures | $207K | -85.9% |
| Investing Cash Flow | -$742K | -121.9% |
| Financing Cash Flow | $4.1M | -71.8% |
| Free Cash Flow | -$7.7M | +37.5% |
| — |
| Net Income | -$15.0M | -70.4% |
| Long-term Debt |
| $144K |
| -47.8% |
| Total Liabilities | $2.9M | -4.0% |
| Stockholders' Equity | $23.9M | -27.2% |